LEADER 01040cam0-22003611i-450-
001 990003843220403321
005 20120525090118.0
010   $a88-464-2634-7
035   $a000384322
035   $aFED01000384322
035   $a(Aleph)000384322FED01
035   $a000384322
100   $a20030910d2000----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $ay-------001cy
200 1 $aMediazione sociale e sociologia$eriferimenti teorici ed esperienze$fa cura di Lucio Luison, Silvia Liaci
210   $aMilano$cFrancoAngeli$d2000
215   $a301 p.$d23 cm
225 1 $aSociologia professionale$v6
610 0 $aConflitti sociali$aMediazione
676   $a303.69$v21$zita
702  1$aLiaci,$bSilvia
702  1$aLuison,$bLucio
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a990003843220403321
952   $a303.69 LUI 1$b703$fBFS
952   $aCollez. 1851 (6)$b37531$fFSPBC
959   $aBFS
959   $aFSPBC
996   $aMediazione sociale e sociologia$9507464
997   $aUNINA

LEADER 02703nam  2200589   450 
001 9910480296503321
005 20170919053637.0
010   $a0-309-37324-7
035   $a(CKB)3710000000513337
035   $a(EBL)4393789
035   $a(SSID)ssj0001692786
035   $a(PQKBManifestationID)16544493
035   $a(PQKBTitleCode)TC0001692786
035   $a(PQKBWorkID)15040543
035   $a(PQKB)25089884
035   $a(MiAaPQ)EBC4393789
035   $a(EXLCZ)993710000000513337
100   $a20160318h20152015  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aFinancial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders $eworkshop summary /$fSheena M. Posey Norris [and three others], rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy
210  1$aWashington, District of Columbia :$cThe National Academies Press,$d2015.
210  4$dİ2015
215   $a1 online resource (128 p.)
300   $aDescription based upon print version of record.
311   $a0-309-37323-9 
320   $aIncludes bibliographical references.
327   $aFrontMatter; Reviewers; Contents; 1 Introduction and Overview; 2 Improving Market Protection; 3 Strengthening the Regulatory Pathway; 4 Patient Benefit and Engagement; Appendix A: References; Appendix B: Workshop Agenda; Appendix C: Registered Attendees; Appendix D: Participant Biographies
606   $aPharmaceutical industry$xEconomic aspects
606   $aDrug development$xEconomic aspects
606   $aCentral nervous system$xDiseases$xEffect of drugs on
606   $aPublic-private sector cooperation
608   $aElectronic books.
615  0$aPharmaceutical industry$xEconomic aspects.
615  0$aDrug development$xEconomic aspects.
615  0$aCentral nervous system$xDiseases$xEffect of drugs on.
615  0$aPublic-private sector cooperation.
676   $a615
702   $aNorris$b Sheena M. Posey
712 02$aInstitute of Medicine (U.S.).$bForum on Neuroscience and Nervous System Disorders.
712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910480296503321
996   $aFinancial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders$92454017
997   $aUNINA